Mallinckrodt to Buy Questcor for $5.6 Billion CHAD BRAY The cash and stock transaction is expected to expand Mallinckrodts offerings of specialty pharmaceuticals primarily Questcors drug Acthar which is used to manage autoimmune and inflammatory conditions. April 7 2014 at 4:00AM http://nyti.ms/1elBX3q http://nyti.ms/1hTmaNT The New York Times Business Day Acthar (Drug) Autoimmune Diseases Boards of Directors Drugs (Pharmaceuticals) Mergers Acquisitions and Divestitures Stocks and Bonds

By CHAD BRAY via NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1elBX3q Mallinckrodt to Buy Questcor for $5.6 Billion The cash and stock transaction is expected to expand Mallinckrodt’s offerings of specialty pharmaceuticals, primarily Questcor’s drug Acthar, which is used to manage autoimmune and inflammatory conditions. April 7, 2014 at 4:00AM http://nyti.ms/1elBX3q http://nyti.ms/1hTmaNT The New York Times Acthar (Drug), Autoimmune Diseases, Boards of Directors, Drugs (Pharmaceuticals), Mergers, Acquisitions and Divestitures, Stocks and Bonds